TNF and Cowden disease: Notably, the higher rates of patient-reported symptoms and extraintestinal manifestations in the complicated CD phenotype cohorts were evident despite these patients receiving TNF inhibitors, corticosteroids, and immunomodulators significantly more often than patients with CD-I.